Dr. Filippo Mulinacci

Responsible for search&evaluation, transactions and in-licensing of oncology products.

Responsible for out-licensing and partnering of proprietary pharmaceutical assets and technologies.

Deal team leader: responsible for identification of game-changing innovation platforms and early stage research opportunities for unmet medical needs, consensus building with senior management, due diligence, contract negotiation alliance management.

Business Development Associate in the Research&Technology group at Roche Partnering in Basel (Switzerland). Responsible for scientific evaluation, identification and triage of new partnering opportunities in the fields of Protein and Antibody Engineering, Drug Discovery, Medicinal Chemistry, Therapeutic Peptides, Stem Cells, Drug Delivery & Formulation, Biomarkers and Cell Therapy.

Research technician in charge of preformulation development for biotherapeutics in the discovery phase (hits and pre-lead protein candidates).

Scientist in charge of analytical development and drug delivery studies for therapeutic proteins and small molecules.

R&D trainee in the Fiber Division Unit.

Manager in charge of the production planning of several brands of cosmetics for the Kelemata/Perlier group. Responsible also for the outsourced productions.

Drug development (formulation and characterization of biotherapeutics). PhD thesis in collaboration with Therapeomic Inc. (Basel, Switzerland)

Analytical chemistry and mass spectrometry